Free tool
FDA Clearance Tracker
Last checked: Nov 20, 2026Latest source record: Nov 8, 2026 (newest decision)openFDA last updated: Nov 9, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Product code KTL: Anti-Dna Indirect Immunofluorescent Solid Phase. Open this device type's page
5 decisions
product code KTL. Showing 1 to 5, newest first. PMA results are original approvals and panel-track supplements.
K231616 · Decided Aug 31, 2023 · 90 days after receipt
Device type: Anti-Dna Indirect Immunofluorescent Solid Phase (KTL) · Laboratory Medicine & Pathology
K203599 · Decided May 26, 2023 · 898 days after receipt
Device type: Anti-Dna Indirect Immunofluorescent Solid Phase (KTL) · Laboratory Medicine & Pathology
K192916 · Decided Dec 11, 2020 · 423 days after receipt
Device type: Anti-Dna Indirect Immunofluorescent Solid Phase (KTL) · Laboratory Medicine & Pathology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.